|
| Frequency (%) | |
| Intervention (n = 27) | Control (n = 30) | |
| Gender |
|
|
| Male | 14 (51.8) | 11 (36.7) |
| Female | 13 (48.2) | 19 (63.3) |
| Marital status |
|
|
| Single | 2 (7.4) | 2 (6.7) |
| Married | 23 (85.2) | 22 (73.3) |
| Divorced or widowed | 2 (7.4) | 6 (20.0) |
| Cancer primary site |
|
|
| Breast | 4 (14.8) | 2 (6.7) |
| Lung and nasopharyngeal | 5 (18.5) | 5 (16.7) |
| Prostate | 6 (22.2) | 1 (3.3) |
| Uterus & ovarian | 1 (3.7) | 4 (13.3) |
| Gastrointestinal Others | 7 (25.9) 4 (14.8) | 3 (9.9) 7 (23.4) |
| Duration of cancer diagnosis |
|
|
| Less than one year | 15 (55.6) | 12 (43.3) |
| One year | 3 (11.1) | 4 (13.3) |
| More than one year | 9 (33.3) | 13 (43.4) |
| Religion |
|
|
| Islam | 26 (96.3) | 29 (96.7) |
| Christine | 1 (3.7) | 1 (3.3) |
| Opioids Therapy |
|
|
| Tramadol | 19 (70.4) | 25 (83.3) |
| Morphine | 8 (29.6) | 5 (16.7) |